Wolfgang Michael Bauer

Country flagAustria

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Summary Background and Objectives Serovar L1–L3 of Chlamydia trachomatis (CT) causes lymphogranuloma venereum (LGV). A surge in LGV‐cases has been observed among HIV‐positive men who have sex with men (MSM). Discrimination between LGV and non‐LGV is pivotal since it has major treatment implications. Here, we aimed to determine the prevalence and characteristics of LGV among CT‐infections. Patients and Methods All CT‐positive results from 04/2014–12/2021 at the four largest Austrian HIV and STI clinics were evaluated. Disease characteristics and patient demographics were analyzed. Results Overall, n = 2,083 infections of CT were documented in n = 1,479 individual patients: median age was 31.4 years, 81% were male, 59% MSM, 44% HIV‐positive, 13% on HIV pre‐exposure‐prophylaxis. Available serovar analyses (61% [1,258/2,083]) showed L1–L3 in 15% (192/1,258). Considering only MSM with rectal CT‐infection, LGV accounted for 23% (101/439). Cases of LGV vs. other CT‐infections were primarily MSM (92% [177/192] vs. 62% [1,179/1,891], p < 0.001), more often HIV‐positive (64% [116/180] vs. 46% [631/1,376]; p < 0.001) and had frequently concomitant syphilis infection (18% [32/180] vs. 7% [52/749]; p < 0.001). LGV commonly manifested as proctitis (38% [72/192]) whereas 45% (87/192) were asymptomatic. Conclusions Lymphogranuloma venereum accounted for 23% of rectal CT‐infections in MSM. Furthermore, 45% of all LGV‐cases were asymptomatic. In the absence of CT‐serovar analysis, a high LGV prevalence should be considered in risk‐populations and guide empiric treatment selection.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (11)

Astrid Erber

Medical University of Vienna

AUSTRIA
View details

Martin Berli

Head

-

SWITZERLAND
View details

Alessandra Handisurya

-

AUSTRIA
View details

Tamar Kinaciyan

Prof., MD, Head of Clinical Allergology and Pediatric Dermatology Clinics

Medical University of Vienna

AUSTRIA
View details

Peter Petzelbauer

Medical University of Vienna

AUSTRIA
View details

Annette Høgh

Aarhus University

DENMARK
View details

David Chromy

Medical University of Vienna

AUSTRIA
View details

Patrick M. Brunner

Associate Professor

Icahn School of Medicine at Mount Sinai

UNITED STATES
View details

Julia Walochnik

Medical University of Vienna

AUSTRIA
View details

Lars French

Professor and Chairman

Ludwig-Maximilians-Universität München

GERMANY
View details

Robert Strassl

Medical University of Vienna

AUSTRIA
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.